Clearance Summary
Exofin Precision Pen received FDA 510(k) clearance under submission number K212246, sponsored by Chemence Medical, Inc.. The device was reviewed via the Special premarket notification pathway and assigned to the General, Plastic Surgery review panel. The statutory decision date of record is 2021-09-09.
- Submission: K212246
- Applicant / Sponsor: Chemence Medical, Inc.
- Clearance pathway: Special
- Review panel: General, Plastic Surgery
- Device class: Class II
- Regulation citation: 21 CFR 878.4010
- Decision date: 2021-09-09
Classification & Regulation
This clearance is catalogued under FDA product code MPN and 21 CFR 878.4010, within the General, Plastic Surgery review panel as a Class II device.